Study of Stapokibart Injection in Patients With Allergic Rhinitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a Randomized, Double-blind, Placebo-controlled phase II clinical study evaluating the efficacy and safety of Stapokibart injection in patients with allergic rhinitis.
Epistemonikos ID: 2bcfe857a3bd5651dba7081eca31a7d87d2f0316
First added on: Aug 01, 2024